Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03701321
Brief Title: Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma

First Submitted : October 8, 2018
First Submitted that Met QC Criteria : October 8, 2018
First Posted : October 10, 2018

Last Update Submitted that Met QC Criteria : April 17, 2019
Last Update Posted : April 18, 2019 (Estimate)